Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Adverse reactions in the treatment of patients with non-tuberculous lung mycobacterial pulmonary disease and the possibility of their solution].

Terapevticheskii arkhiv·2024
Same author

[New clinical guidelines for COPD - a paradigm shift: A review].

Terapevticheskii arkhiv·2024
Same author

[Pulmonary fibrosis after a new coronavirus infection - versions and controversies: A review].

Terapevticheskii arkhiv·2024
Same author

Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases.

Terapevticheskii arkhiv·2023
Same author

[Respiratory diseases and obesity: special phenotype or independent events: Review].

Terapevticheskii arkhiv·2022
Same author

[Non - tuberculous mycobacteriosis of the lungs - diagnostic possibilities in the practice of the pulmonologist].

Terapevticheskii arkhiv·2020

Related Experiment Video

Updated: May 11, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

[Mucoactive therapy in pulmonological practice: current aspects].

N M Shmeleva, E I Shmelev

    Terapevticheskii Arkhiv
    |May 31, 2013
    PubMed
    Summary

    This study explores mucostasis causes and mucolytic drug classifications. It highlights combination mucolytics, like Ascoril, detailing their design, use, and successful outcomes for treating respiratory conditions.

    Area of Science:

    • Respiratory Medicine
    • Pharmacology

    Context:

    • Mucostasis, characterized by impaired mucus clearance, is a significant factor in respiratory diseases.
    • Understanding the pathophysiology of mucostasis is crucial for developing effective therapeutic strategies.

    Purpose:

    • To elucidate the underlying causes and mechanisms of mucostasis.
    • To classify existing mucolytic drugs and identify optimal combination therapies.
    • To evaluate the efficacy of specific combination mucolytics, such as Ascoril.

    Summary:

    • The paper details the etiology and pathogenesis of mucostasis.
    • It provides a comprehensive classification of mucolytic agents.
    • Combination mucolytic drugs are analyzed, with a focus on Ascoril's formulation, application, and demonstrated clinical success.

    More Related Videos

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
    05:56

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

    Published on: May 12, 2023

    Related Experiment Videos

    Last Updated: May 11, 2026

    Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
    04:03

    Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

    Published on: September 27, 2024

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
    05:56

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

    Published on: May 12, 2023

    Impact:

    • Provides a framework for understanding and managing mucostasis.
    • Offers insights into the rational design and use of combination mucolytic therapies.
    • Supports evidence-based clinical practice for respiratory ailments involving mucus hypersecretion.